Skip to content
Recall Observatory FDA recall evidence

Drug product

Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.

D-0001-2025

September 24, 2024

Class II

Product summary

Firm
Nivagen Pharmaceuticals Inc
Event
Event 95418
Status
Terminated
Classification
Class II
Quantity
2328 bottles
Official record key
drug-enforcement:D-0001-2025

Official wording

Reason: Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.

Code information: Lot #: U24T0408A, Exp: 03/31/2026

Distribution pattern: Nationwide within the U.S

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets